期刊文献+

先天性低促性腺激素性性腺功能减退症的诊治进展 被引量:6

Update of diagnosis and treatment for congenital hypogonadotropic hypogonadism
原文传递
导出
摘要 先天性低促性腺激素性性腺功能减退症是因促性激素释放激素或促性腺激素产生不足、分泌障碍或活性缺失导致的疾病,其主要特征为性征缺失和不育。目前已发现多种致病基因与之相关,同时环境内分泌干扰物等因素也参与、促进该病形成。该病常见的疾病类型有Kallmann综合征、Prader-Willi综合征、多垂体激素缺乏症等。新生儿期和婴儿早期是该病诊断的黄金时期。对于青春期的患者,临床医师需注意将其与体质性青春期生长发育延迟相鉴别。在治疗方式上,需要根据患者的年龄、性别及对生育能力的要求进行选择。治疗的方法有性激素替代治疗、促性腺激素治疗和促性腺激素释放激素泵治疗。尽早诊断与治疗可诱导并维持第二性征,诱导男性精子形成和女性排卵,减少因该病导致的心理问题。该文对该病的诊断和治疗进展作出综述。 Congenital hypogonadotropic hypogonadism, mainly characterized by absence of puberty and infertility,is a disorder due to deficient production, secretion or activity of gonadotropin-releasing hormone or gonadotropins. Multiple causative genes have been found till now, and other factors like environmental endocrine disruptors also participate in promoting the disease at the same time. Common diseases in this category are Kall- mann syndrome, Prader-Willi syndrome and multiple pituitary hormone deficiency. Neonatal period and early in- fancy are golden time for diagnosis of the disorder. Constitutional growth delay of puberty should be considered in the differential diagnosis for adolescent patients. Therapeutic schedule should be selected according to age, gender and demand for fertility. The treatment can be sexual hormone replacement, gonadotropin therapy and pul- satile pump gonadotropin-releasing hormone. A timely diagnosis and treatment can induce and maintain second sexual characteristics, enhance the male spermatogenesis and female ovulation and reduce psychological problems caused by the disorder. This article is to review the update in diagnosis and treatment of the disorder.
作者 葛娟 李堂
出处 《国际儿科学杂志》 2017年第11期769-772,共4页 International Journal of Pediatrics
关键词 性腺功能减退症 KALLMANN综合征 诊断 治疗 Hypogonadism Kallmann Syndrome Diagnosis Therapeutics
  • 相关文献

参考文献5

二级参考文献66

  • 1伍学焱,史轶蘩,邓洁英,潘慧,卢双玉,姜亚云,吴勤勇,张景玲.大庆市健康男性青少年正常青春发育时间调查[J].中华医学杂志,2007,87(16):1117-1119. 被引量:8
  • 2Raivio T, Falardeau J, Dwyer A, et al. Reversal of idiopathic hypogonadotropic hypogonadism [ J]. New Engl J Med, 2007, 357 (9) :863-873.
  • 3Kanika G, Cara F, Robert L, et al. Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age, boys-a clinical research center study [ J]. Clin Endocrinol Metab, 1995, 80(10) :2980-2986.
  • 4曲普瑞林:药物临床信息参考[M].成都:四川科学技术出版社,2004:869-690.
  • 5Semple RK, Topaloglu AK. The recent genetics of hypogonadotrophic hypogonadism-novel insights and new questions [J]. Clin Endocrinol (Oxf), 2010, 72(4):427-435.
  • 6David W, Genevieve D, Pharm D, et al. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin [ J ]. Fertil Steril, 2009, 92 (2) :594-604.
  • 7Rider CV,Wilson VS, Howdeshel KL, et al. Cumulative effects of in utero administration of mixtures of " antiandrogens" on male rat reproductive development. Toxicol Pathol,2009,37( 1 ) : 100-113.
  • 8Bourguignon JP, Parent AS. Early homeostatic disturbances of human growth and maturation by endocrine disrupters. Curt Opin Pediatr, 2010,22(4) :470-477.
  • 9Mouritsen A, Aksglaede L, Sorensen K, et al. Hypothesis:exposure to endocrine-disrupting chemicals may interfere with timing of puberty. Int J Androl,2010,33(2):346-359.
  • 10Kim TS,Jung KK,Kim SS,et al. Effects of in utero exposure to DI( n- Butyl) phthalate on development of male reproductive tracts in spague-dawley rat. J Toxicol Env Heal A, 2010,3 ( 21-22 ) : 1544- 1559.

共引文献29

同被引文献45

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部